BEAT
HeartBeam, Inc.
NASDAQ · Healthcare · Medical - Healthcare Information Services · US
$0.43
+1.59%Aug 14, 2026, 06:47 UTC
HeartBeam, Inc. held its Q2 2026 earnings call on August 14, 2026.
Source:Aug 14, 2026, 00:00 UTC
HeartBeam, Inc. signed an at-the-market equity offering sales agreement with Titan Partners Securities LLC, allowing HeartBeam to sell up to $25,000,000 of its common stock from time to time, with Titan Partners receiving a commission of up to 3% of gross sales price.
Jul 14, 2026, 12:00 UTC
HeartBeam, Inc. was awarded a new U.S. patent that expands the acoustic sensing and fluid monitoring capabilities of its cable-free ECG device.
Source:Jun 25, 2026, 15:50 UTC
HeartBeam announced a strategic reorganization to accelerate commercialization, with Founder Branislav Vajdic and Executive Chairman Rich Ferrari leading implementation teams, and former CEO Robert Eno moving to a consulting role.
Source:Jun 24, 2026, 00:00 UTC
Branislav Vajdic, Ph.D. will become interim Chief Executive Officer and President of HeartBeam, Inc. effective July 1, 2026.
Jun 24, 2026, 00:00 UTC
Mark Strome resigned as a member of the Board of Directors of HeartBeam, Inc. effective June 18, 2026.